Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
We have previously reported suggestive linkage of type 2 diabetes mellitus to chromosome 10q. We genotyped 228 microsatellite markers in Icelandic individuals with type 2 diabetes and controls throughout a 10.5-Mb interval on 10q. A microsatellite, DG10S478, within intron 3 of the transcription factor 7-like 2 gene (TCF7L2; formerly TCF4) was associated with type 2 diabetes (P = 2.1 x 10(-9)). This was replicated in a Danish cohort (P = 4.8 x 10(-3)) and in a US cohort (P = 3.3 x 10(-9)). Compared with non-carriers, heterozygous and homozygous carriers of the at-risk alleles (38% and 7% of the population, respectively) have relative risks of 1.45 and 2.41. This corresponds to a population attributable risk of 21%. The TCF7L2 gene product is a high mobility group box-containing transcription factor previously implicated in blood glucose homeostasis. It is thought to act through regulation of proglucagon gene expression in enteroendocrine cells via the Wnt signaling pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The majority of associated loci are linked to beta cells, supporting the idea that impaired beta cell function is critical to type 2 diabetes pathogenesis78,80.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [78]
In the citing paper
“The first associated loci, in genes including TCF7L2, INSR, IRS1, GCK and KCNJ11 (refs.77,78), were originally identified by linkage or candidate gene studies, and since the turn of the century, increasing size and depth of genome-wide association studies have rapidly expanded the list of associated loci in type 2 diabetes to more than 250 with 400 independent signals79.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [78]
In the citing paper
“unequivocal replications are so far limited to variants in just three genes: PPARG, KCNJ11 and TCF7L2 (2-4).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [4]
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“The prevalence of type 2 diabetes worldwide is 6% but is projected to rise over the next decade owing to increasing age of the population and surge of obesit”
BackgroundConvergence of Wnt, ß-Catenin, and Cadherin Pathways
Nelson, W. J., & Nusse, R. (2004) · Science · doi:10.1126/science.1094291 · Cited by 2,515 · cited 1×
“The β-catenin protein is also important for mediating cell adhesion through its binding of cadherin”
BackgroundThe common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4
Korinek, V., Barker, N., Moerer, P., van Donselaar, E., Huls, G., Peters, P. J., & Clevers, H. (1998) · Nature Genetics · doi:10.1038/1270 · Cited by 1,581
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E. H., et al. (2000) · Nature Genetics · doi:10.1038/79876 · Cited by 1,468
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123 · cited 1×
“Similar to TCF7L2 , five of the six positionally cloned genes for the rare mendelian forms of type 2 diabetes, maturity-onset diabetes of the young (MODY), are transcription factor”
BackgroundAllele-Sharing Models: LOD Scores and Accurate Linkage Tests
Kong, A., & Cox, N. J. (1997) · The American Journal of Human Genetics · doi:10.1086/301592 · Cited by 979
Self-citationGloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Cited by
Items 301–400 of 1,004
Zhao, J. H. (2007) · Journal of Statistical Software · doi:10.18637/jss.v023.i08 · Cited by 116
Genetics Insights in the Relationship Between Type 2 Diabetes and Coronary Heart Disease
Goodarzi, M. O., & Rotter, J. I. (2020) · Circulation Research · doi:10.1161/circresaha.119.316065 · Cited by 141
Oxidative stress: Biomarkers and novel therapeutic pathways
Maiese, K., Chong, Z. Z., Hou, J., & Shang, Y. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.01.004 · Cited by 120
“Abnormalities in the Wnt pathway, such as with transcription factor 7-like 2 gene, may impart increased risk for type 2 diabetes in some populations (Grant et al., 2006; Lehman et al., 2007; Scott et al., 2006) as well as have increased association with obesity (Guo et al.”
BackgroundThe discovery of human genetic variations and their use as disease markers: past, present and future
Ku, C., Loy, E. Y., Salim, A., Pawitan, Y., & Chia, K. S. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.55 · Cited by 138
Ip, W., Chiang, Y.-T. A., & Jin, T. (2012) · Cell & Bioscience · doi:10.1186/2045-3701-2-28 · Cited by 128
“reported their major discovery on the linkage between polymorphisms in TCF7L2 and the risk of T2D [13].”
BackgroundShao, W., Wang, D., Chiang, Y., Ip, W., Zhu, L., Xu, F., Columbus, J., Belsham, D. D., Irwin, D. M., Zhang, H., et al. (2012) · Diabetes · doi:10.2337/db12-0365 · Cited by 124
“Extensive genome-wide association studies have revealed that specific single-nucleotide polymorphisms (SNPs) in TCF7L2 are strongly associated with the susceptibility of type 2 diabetes (1).”
BackgroundAquilante, C. L. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.154 · Cited by 139
Nucleoredoxin, a Novel Thioredoxin Family Member Involved in Cell Growth and Differentiation
Funato, Y., & Miki, H. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1550 · Cited by 126
“In addition, many reports suggest the relation between the Wnt signaling pathway and diabetes or underlying adipogenesis (38, 42, 152).”
Genetics of Type 2 Diabetes: Implications from Large-Scale Studies
DeForest, N., & Majithia, A. R. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01462-3 · Cited by 142
The GK Rat: A Prototype for the Study of Non-overweight Type 2 Diabetes
Portha, B., Giroix, M.-H., Tourrel‐Cuzin, C., Stunff, H. L., & Movassat, J. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-068-7_9 · Cited by 136
Erythropoietin: Elucidating new cellular targets that broaden therapeutic strategies
Maiese, K., Chong, Z. Z., Li, F., & Shang, Y. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.02.002 · Cited by 119
Genetics of Type 2 Diabetes: Insights into the Pathogenesis and Its Clinical Application
Sun, X., Yu, W., & Hu, C. (2014) · BioMed Research International · doi:10.1155/2014/926713 · Cited by 111
Lehman, D. M., Hunt, K. J., Leach, R. J., Hamlington, J. D., Arya, R., Abboud, H. E., Duggirala, R., Blangero, J., Göring, H. H. H., & D, M. P. S. M. (2007) · Diabetes · doi:10.2337/db06-0860 · Cited by 111
“The variant of TCF7L2 that has been observed to be associated with type 2 diabetes is a microsatellite marker (DG10S478) located in intron 3 (1).”
BackgroundResultInfluentialCornelis, M. C., Tchetgen, E. J. T., Liang, L., Qi, L., Chatterjee, N., Hu, F. B., & Kraft, P. L. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr368 · Cited by 120
Imamura, M., Maeda, S., Yamauchi, T., Hara, K., Yasuda, K., Morizono, T., Takahashi, A., Horikoshi, M., Nakamura, M., Fujita, H., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds113 · Cited by 111
“The first round of GWAS for type 2 diabetes reported in 2007 confirmed five new loci—HHEX, SLC30A8, CDKAL1, CDKN2A-CDKN2B and IGF2BP2 (3–7)—in addition to three previously reported loci—TCF7L2 (8), PPARG (9) and KCNJ11 (10).”
BackgroundThe success of the genome-wide association approach: a brief story of a long struggle
Seng, K. C., & Seng, C. K. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.12 · Cited by 123
“In 2006, TCF7L2 gene was first reported to be associated with T2D by deCODE Genetics, who fine mapped a suggestive linkage region identified previously in an Icelandic population”
BackgroundDNA Methylation as a Diagnostic and Therapeutic Target in the Battle Against Type 2 Diabetes
Rönn, T., & Ling, C. (2015) · Epigenomics · doi:10.2217/epi.15.7 · Cited by 116
Cai, T., Dufour, J., Muellhaupt, B., Gerlach, T. J., Heim, M. H., Moradpour, D., Cerny, A., Malinverni, R., Kaddai, V., Bochud, M., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.020 · Cited by 114
“TCF7L2 is involved in the susceptibility to type 2 diabetes [39] and NAFLD [40].”
BackgroundAbnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice
da Silva Xavier, G., Mondragon, A., Sun, G., Chen, L., McGinty, J. A., French, P. M., & Rutter, G. A. (2012) · Diabetologia · doi:10.1007/s00125-012-2600-7 · Cited by 109
“The TCF7L2 gene, located on chromosome 10 in a region tentatively associated with type 2 diabetes in 2003 [13], was directly associated with the disease in Icelandic and other northern European populations by Grant et al [14].”
Frietze, S., Wang, R., Yao, L., Tak, Y. G., Ye, Z., Gaddis, M., Witt, H., Farnham, P. J., & Jin, V. X. (2012) · Genome Biology · doi:10.1186/gb-2012-13-9-r52 · Cited by 109
“In addition to being linked to neoplastic transformation, variants in TCF7L2 are thought to be the most critical risk factors for type 2 diabetes [7-10].”
BackgroundNg, M. C. Y., Tam, C. H. T., Lam, V. K. L., So, W., Ronald, C. W., & Chan, J. C. N. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0849 · Cited by 116
“(chromosome 10: 114,723–114,815 kb, NCBI Build 35) (1).”
BackgroundInfluentialShaat, N., Lernmark, Å., Karlsson, E., Ivarsson, S. A., Parikh, H. M., Berntorp, K. E., & Groop, L. (2007) · Diabetologia · doi:10.1007/s00125-007-0623-2 · Cited by 116
“However, for some of the DBS samples, the ADIPOQ +276G>T polymorphism was genotyped by RFLP where 20 μl of the template PCR product was digested with Mva 1269I (Fermentas, St LeonRot, Germany) at 37°C for 4 h. PCR products were separated on 3% agarose gel (SeaKem, Rockland, ME, USA) and stained with ethidium bromide t…”
BackgroundResultInfluentialFamilial Clustering of Chronic Kidney Disease
Satko, S. G., Sedor, J. R., Iyengar, S. K., & Freedman, B. I. (2007) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00282.x · Cited by 115
The new type 2 diabetes gene TCF7L2
Florez, J. C. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3281e2c9be · Cited by 124
Latent Autoimmune Diabetes in Adults: Current Status and New Horizons
Pozzilli, P., & Pieralice, S. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.2.147 · Cited by 131
Diabetes in China: epidemiology, pathophysiology and multi-omics
Jia, W., Chan, J. C. N., Wong, T. Y., & Fisher, E. B. (2025) · Nature Metabolism · doi:10.1038/s42255-024-01190-w · Cited by 118
Iwata, M., Maeda, S., Kamura, Y., Takano, A., Kato, H., Murakami, S., Higuchi, K., Takahashi, A., Fujita, H., Hara, K., et al. (2012) · Diabetes Care · doi:10.2337/dc11-2006 · Cited by 107
Tissue-specific alternative splicing of TCF7L2
Prokunina‐Olsson, L., Welch, C., Hansson, O., Adhikari, N., Scott, L. J., Usher, N., Tong, M., Sprau, A. G., Swift, A. J., Bonnycastle, L. L., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp321 · Cited by 112
“Common genetic variants within the transcription factor 7-like 2 gene (TCF7L2, previously known as T-cell factor 4, or TCF-4) have been strongly associated with increased risk of type 2 diabetes (T2D) (1).”
BackgroundInfluentialLatent Autoimmune Diabetes in Adults: A Review on Clinical Implications and Management
Pieralice, S., & Pozzilli, P. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0190 · Cited by 102
Bagchi, D. P., Nishii, A., Li, Z., DelProposto, J. B., Corsa, C. A. S., Mori, H., Hardij, J., Learman, B. S., Lumeng, C. N.-K., & MacDougald, O. A. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101078 · Cited by 120
Gumede, D. B., Abrahamse, H., & Houreld, N. N. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01623-9 · Cited by 120
“Mutations on the TCF7L2 genes lead to the dysfunction of pancreatic beta cells [133, 135].”
BackgroundFreathy, R. M., Hayes, M. G., Urbanek, M., Lowe, L. P., Lee, H., Ackerman, C., Frayling, T. M., Cox, N. J., Dunger, D. B., Dyer, A. R., et al. (2010) · Diabetes · doi:10.2337/db10-0177 · Cited by 106
Sale, M. M., Smith, S. G., Mychaleckyj, J. C., Keene, K. L., Langefeld, C. D., Leak, T. S., Hicks, P. J., Bowden, D. W., Rich, S. S., & Freedman, B. I. (2007) · Diabetes · doi:10.2337/db07-0012 · Cited by 113
Common variant at 16p11.2 conferring risk of psychosis
Steinberg, S., de Jong, S., Mattheisen, M., Costas, J., Demontis, D., Jamain, S., Pietiläinen, O. P. H., Lin, K., Papiol, S., Huttenlocher, J., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2012.157 · Cited by 104
Self-citationIs Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum
Ríos, J. A., Cisternas, P., Arrese, M. A., Salesa Barja, Y., & Inestrosa, N. C. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.07.004 · Cited by 110
Progress in the genetics of common obesity and type 2 diabetes
Vimaleswaran, K. S., & Loos, R. J. F. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001389 · Cited by 107
Genetics of preeclampsia: paradigm shifts
Oudejans, C. B. M., van Dijk, M., Oosterkamp, M., Lachmeijer, A. M. A., & Blankenstein, M. A. (2006) · Human Genetics · doi:10.1007/s00439-006-0259-1 · Cited by 121
“…for the two genes (complement factor B, CBF; complement component 2, C2) associated with age-related macular degeneration and can be expected to be the case for the variant of transcription factor 7-like 2 gene (TCF7L2) associated with type 2 diabetes (Gold et al. 2006; Grant et al. 2006).”
BackgroundGustafson, B., & Smith, U. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.102855 · Cited by 110
Ancestry-Shift Refinement Mapping of the C6orf97-ESR1 Breast Cancer Susceptibility Locus
Stacey, S., Sulem, P., Zanon, C., Gudjonsson, S. A., Þorleifsson, G., Helgason, A., Jónasdóttir, Á., Besenbacher, S., Kostic, J. P., Fackenthal, J. D., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001029 · Cited by 113
“We estimated the inflation factor using a previously described procedure in which genotypes were simulated through the genealogy of 731,175 Icelanders and the x(2) corrected statistics accordingly [32].”
MethodSelf-citationMitchell, R. K., Mondragon, A., Chen, L., McGinty, J., French, P. M. W., Ferrer, J. P., Thorens, B., Hodson, D. J., Rutter, G. A., & Xavier, G. D. S. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu553 · Cited by 112
“First described in Icelandic, Danish and US cohorts (7) SNP rs7903146 is presently the most strongly associated of the GWAS-identified variants with T2D (7–10) and is also associated with latent autoimmune diabetes in adults (11).”
BackgroundSchinner, S., Ülgen, F., Papewalis, C., Schott, M., Woelk, A., Vidal‐Puig, A., & Scherbaum, W. A. (2007) · Diabetologia · doi:10.1007/s00125-007-0848-0 · Cited by 108
“However, the mechanisms through which TCF7L2 affects glucose metabolism are not clear [14, 15].”
BackgroundTan, S., Scherag, A., Janssen, O. E., Hahn, S., Lahner, H., Dietz, T., Scherag, S., Grallert, H., Vogel, C. I. G., Kimmig, R., et al. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-12 · Cited by 102
“Identified via a conventional genome wide linkage scan for T2DM and subsequent fine mapping [21], it had convincingly been confirmed in numerous studies including GWAS [22-24].”
BackgroundEpigenetics and maternal nutrition: nature v. nurture
Simmons, R. (2011) · Proceedings of the Nutrition Society · doi:10.1017/s0029665110003988 · Cited by 103
“The recently described T2D susceptibility gene transcription factor 7-like 2 confers a risk-allele frequency of approximately 30%((32)).”
Genetic predisposition to type 2 diabetes among Asian Indians.
Radha, V., & Mohan, V. (2007) · PubMed · Cited by 130
Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine
Mannino, G. C., Andreozzi, F., & Sesti, G. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3109 · Cited by 117
Nutrition, the visceral immune system, and the evolutionary origins of pathogenic obesity
West-Eberhard, M. J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809046116 · Cited by 98
Gebhardt, R., & Hovhannisyan, A. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22041 · Cited by 102
Genetics of Cardiovascular Diseases: From Single Mutations to the Whole Genome
Cambien, F., & Tiret, L. (2007) · Circulation · doi:10.1161/circulationaha.106.661751 · Cited by 125
TCF7L2 and type 2 diabetes—we WNT to know
Smith, U. (2006) · Diabetologia · doi:10.1007/s00125-006-0521-z · Cited by 102
“[1] that variants in the TCF7L2 gene are strongly associated with risk of developing type 2 diabetes has now been robustly reproduced in many other populations.”
BackgroundUrano, T., Shiraki, M., Ouchi, Y., & Inoue, S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1218 · Cited by 101
Dyck, P. J., Davies, J. L., Clark, V. M., Litchy, W. J., Dyck, P. J. B., Klein, C. J., Rizza, R. A., Pach, J. M., Klein, R., Larson, T. S., et al. (2006) · Diabetes Care · doi:10.2337/dc06-0525 · Cited by 99
Challenges in human genetic diversity: demographic history and adaptation
Balaresque, P. L., Ballereau, S. J., & Jobling, M. A. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm242 · Cited by 98
“The finding of selection signatures in Europeans and East Asians suggests that there really is some selective advantage for light skin, and the fact that they are in different genes shows that evolutionary routes to similar phenotypes were distinct – convergent evolution (30,32,33).”
BackgroundThe Alliance of Mesenchymal Stem Cells, Bone, and Diabetes
Napoli, N., Strollo, R., Paladini, A., Briganti, S., Pozzilli, P., & Epstein, S. (2014) · International Journal of Endocrinology · doi:10.1155/2014/690783 · Cited by 110
“showed that the TCF7L2 variant 7903146, the main T2D associated gene [229], modifies the effect of incretins on insulin secretion [230].”
BackgroundThe Impact of Divergence Time on the Nature of Population Structure: An Example from Iceland
Price, A. L., Helgason, A., Palsson, S., Stefansson, H., St. Clair, D., Andreassen, O. A., Reich, D., Kong, A., & Stefansson, K. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000505 · Cited by 103
“The Icelandic population has been sampled in many disease association studies [1–8].”
MethodSelf-citationCheng, C.-Y., Reich, D., Haiman, C. A., Tandon, A., Patterson, N., Elizabeth, S., Akylbekova, E. L., Brancati, F. L., Coresh, J., Boerwinkle, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032840 · Cited by 97
“Despite remarkable efforts in the past three years that have led to the discovery of more than 30 susceptibility loci for type 2 diabetes and related quantitative traits [5–18], there has been only one genome-wide association study of type 2 diabetes in African Americans [19].”
Cross-talk between Insulin and Wnt Signaling in Preadipocytes
Palsgaard, J., Emanuelli, B., Winnay, J. N., Sumara, G., Karsenty, G., & Kahn, C. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.337048 · Cited by 98
“Furthermore, one of themain transcription factors downstream the Wnt signaling pathway, TCF7L2, has been implicated as an important gene in the development of type 2 diabetes (18).”
BackgroundInherited Genetic Susceptibility to Breast Cancer
Ghoussaini, M., Pharoah, P. D. P., & Easton, D. F. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.07.003 · Cited by 123
“The TCF7L2 is a protooncogene, an important component of the WNT pathway, and well known for its association with type 2 diabetes.(76) The MAPKAPKs have a pivotal role in the cell mitogenic processes and survival and are directly regulated by MAPKs.”
BackgroundRacialized Genetics and the Study of Complex Diseases: The Thrifty Genotype Revisited
Paradies, Y., Montoya, M. J., & Fullerton, S. M. (2007) · Perspectives in biology and medicine · doi:10.1353/pbm.2007.0020 · Cited by 111
“By this criterion, they identify only three genes, PPARG, KCNJ11, and TCF7L2, as having been reproducibly associated with T2DM (Altshuler et al. 2000; Grant et al. 2006; Hani et al. 1998).”
BackgroundJonsson, A., Ladenvall, C., Ahluwalia, T. S., Kravic, J., Krus, U., Taneera, J., Isomaa, B., Tuomi, T., Renström, E., Groop, L., et al. (2013) · Diabetes · doi:10.2337/db12-1627 · Cited by 99
Hanson, R. L., Bogardus, C., Duggan, D., Kobes, S., Knowlton, M., Infante, A. M., Marovich, L., Benitez, D., Baier, L. J., & Knowler, W. C. (2007) · Diabetes · doi:10.2337/db07-0462 · Cited by 98
Schadt, E. E., & Lum, P. Y. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r600026-jlr200 · Cited by 101
“Notable examples are TCF7L2, a major disease gene for common forms of type 2 diabetes (1, 2); INSIG2, a major obesity gene potentially explaining 4% of lifetime body mass index (BMI) in the human population (3); CFH, one of the more striking discoveries for age-related macular degeneration, where a number of sequence…”
TCF7L2 Variation Predicts Hyperglycemia Incidence in a French General Population
Cauchi, S., Meyre, D., Choquet, H., Dina, C., Born, C., Marre, M., Balkau, B., Froguel, P., & for the DESIR Study Group (2006) · Diabetes · doi:10.2337/db06-0692 · Cited by 99
“Although the allelic ORs are substantially lower than in other studies, the CIs of the genotypic ORs (C/C versus C/T and C/T versus TT, one being the wild-type allele) overlap with previously published estimations (1,2).”
BackgroundResultInfluentialMolecular Determinants of Liver Zonation
Torre, C., Perret, C., & Colnot, S. (2010) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385233-5.00005-2 · Cited by 97
Identification of Type 2 Diabetes-associated combination of SNPs using Support Vector Machine
Ban, H., Heo, J. Y., Oh, K.-S., & Park, K.-J. (2010) · BMC Genetics · doi:10.1186/1471-2156-11-26 · Cited by 115
“In the T2D studies, candidate gene or genome-wide association approaches have suggested various putative T2D susceptibility SNP variants in various genes including TCF7L2, PPARG, KCNJ11, CDKN2A/B, FTO, CDKAL1 and so on [6-10].”
Saadi, H., Nagelkerke, N. J. D., Carruthers, S. G., Benedict, S., Abdulkhalek, S., Reed, R. L., Lukić, M. L., & Nicholls, M. G. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.01.008 · Cited by 107
Hertel, J. K., Johansson, S., Ræder, H., Midthjell, K., Lyssenko, V., Groop, L., Molven, A., & Njølstad, P. R. (2008) · Diabetologia · doi:10.1007/s00125-008-0982-3 · Cited by 100
“Thorsby, unpublished results) and with an OR similar to other studies [16, 17], indicating that the HUNT population contains a representative diabetes cohort and that our genotyping strategy was robust.”
ResultTian, L., Song, Z., Shao, W., Du, W. W., Zhao, L. R., Zeng, K., Yang, B. B., & Jin, T. (2017) · Cell Death and Disease · doi:10.1038/cddis.2016.455 · Cited by 103
“Ahn and colleagues,(15) however, did not examine the Wnt pathway effector Tcf7l2, of which the human homologue is an important diabetes risk gene.(7,8) Based on a recent study that miR-17-5p repressed another TCF member TCF7L1 in another cell lineage(13) and a previous investigation that miR-17/92 cluster over-express…”
BackgroundPharmacogenetics of Anti-Diabetes Drugs
DiStefano, J. K., & Watanabe, R. M. (2010) · Pharmaceuticals · doi:10.3390/ph3082610 · Cited by 110
“populations [87-100].”
Rees, S. D., Hydrie, M. Z. I., Shera, A. S., Kumar, S., O’Hare, J. P., Barnett, A. H., Basit, A., & Kelly, M. A. (2011) · Diabetologia · doi:10.1007/s00125-011-2063-2 · Cited by 104
“Over the last 4 years, large-scale association studies, in particular genome-wide association (GWA) studies, have increased the number of accepted type 2 diabetes susceptibility variants to over 30 [2–11].”
BackgroundAssociation of SIRT1 gene variation with visceral obesity
Peeters, A. V., Beckers, S., Verrijken, A., Mertens, I. L., Roevens, P. W. M., Peeters, P. J., Hul, W. V., & Gaal, L. F. V. (2008) · Human Genetics · doi:10.1007/s00439-008-0567-8 · Cited by 107
“…for discovering the genetic causes of complex diseases and although several recent successes can be ascribed to the method (Frayling et al. 2007; Grant et al. 2006), genes with a small eVect are more likely to be missed as weak association signals are lost in the background noise or are Wltered…”
BackgroundSuccessful Versus Failed Adaptation to High-Fat Diet–Induced Insulin Resistance
Matveyenko, A. V., Gurlo, T., Daval, M., Butler, A. E., & Butler, P. C. (2009) · Diabetes · doi:10.2337/db08-1464 · Cited by 98
Type-2 diabetes: a cocktail of genetic discovery
Freeman, H. C., & Cox, R. D. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl191 · Cited by 111
“(12) reported a variant of the transcription factor 7-like 2 gene (TCF7L2), conferring an allele relative risk (RR) of 1.”
BackgroundFunctional Variants of the <emph type="ital">HMGA1</emph> Gene and Type 2 Diabetes Mellitus
Chiefari, E. (2011) · JAMA · doi:10.1001/jama.2011.207 · Cited by 97
“5) [34-86] 66.”
TCF7L2 Is Not a Major Susceptibility Gene for Type 2 Diabetes in Pima Indians
Guo, T., Hanson, R. L., Traurig, M. T., Muller, Y. L., Ma, L., Mack, J. L., Kobes, S., Knowler, W. C., Bogardus, C., & Baier, L. J. (2007) · Diabetes · doi:10.2337/db07-0621 · Cited by 97
“(1), and these modest haplotype associations could be attributed to multiple variant testing.”
BackgroundHypertension-Associated Kidney Disease: Perhaps no More
Freedman, B. I., & Sedor, J. R. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060621 · Cited by 104
Effects of TCF7L2 Polymorphisms on Obesity in European Populations
Cauchi, S., Choquet, H., Gutiérrez‐Aguilar, R., Capel, F., Grau, K., Cavalcanti-Proença, C., Christian Dina, C., Duval, A., Balkau, B., Marre, M., et al. (2008) · Obesity · doi:10.1038/oby.2007.77 · Cited by 94
“Grant and colleagues initially reported a strong association of the transcription factor 7-like 2 (TCF7L2) rs7903146 T allele with type 2 diabetes (T2D) in populations of North European descent (1).”
BackgroundGenome-wide association with diabetes-related traits in the Framingham Heart Study
Meigs, J. B., Manning, A. K., Fox, C. S., Florez, J. C., Liu, C., Cupples, L. A., & Dupuis, J. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s16 · Cited by 106
“We use FHS 100K SNPs in an in silico replication analysis that tests the hypothesis that SNPs in LD with published causal variants in PPARG , ABCC8 , TCF7L2 , CAPN10 , and HNFa are associated with diabetes and related quantitative traits.”
InfluentialElbein, S. C., Chu, W. S., Das, S. K., Yao‐Borengasser, A., Hasstedt, S. J., Wang, H., Rasouli, N., & Kern, P. A. (2007) · Diabetologia · doi:10.1007/s00125-007-0717-x · Cited by 103
“Based on strong linkage disequilibrium between the SNPs and the dichotomised microsatellite [4], only the SNPs were typed for family and metabolic studies.”
BackgroundMethodInfluentialMattei, J., Qi, Q., Hu, F. B., Sacks, F. M., & Qi, L. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.038125 · Cited by 99
Cropano, C. M., Santoro, N., Groop, L., Man, C. D., Cobelli, C., Galderisi, A., Kursawe, R., Pierpont, B. M., Goffredo, M., & Caprio, S. (2017) · Diabetes Care · doi:10.2337/dc17-0290 · Cited by 104
“(18) that a common single nucleotide polymorphism (SNP) in the TCF7L2 gene region was associated with T2D in an Icelandic case-control study has launched a new direction in diabetes re-”
BackgroundNorton, L., Fourcaudot, M. J., Abdul-Ghani, M. A., Winnier, D. A., Mehta, F. F., Jenkinson, C. P., & DeFronzo, R. A. (2011) · Diabetologia · doi:10.1007/s00125-011-2289-z · Cited by 94
“diabetes susceptibility locus on chromosome 10 [1], which was later refined to a single nucleotide polymorphism within intron 3 of TCF7L2 [2].”
BackgroundMechanisms and risk factors of metabolic syndrome in children and adolescents
Codazzi, V., Frontino, G., Galimberti, L., Giustina, A., & Petrelli, A. (2023) · Endocrine · doi:10.1007/s12020-023-03642-x · Cited by 111
“A meta-analysis of fi ve studies showed that the rs7903146 T allele also increased the risk for MetS in an adult population [46, 64, 65].”
Wnt Signaling in Pancreatic Islets
Liu, Z., & Habener, J. F. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_17 · Cited by 98
Understanding Genetic Factors in Idiopathic Scoliosis, a Complex Disease of Childhood
Wise, C. A., Gao, X., Shoemaker, S., Gordon, D., & Herring, J. A. (2008) · Current Genomics · doi:10.2174/138920208783884874 · Cited by 111
“More recently, successes in identifying genetic loci underlying common diseases such as inflammatory bowel disease, psoriasis, age-related macular degeneration, type 2 diabetes, and coronary heart disease [9-18] have generated increasing interest in applying similar genome-wide approaches in large scale studies of IS.”
BackgroundMuñoz, J. A., Lok, K. H., Gower, B. A., Fernández, J. R., Hunter, G. R., Lara‐Castro, C., Luca, M. D., & Garvey, W. T. (2006) · Diabetes · doi:10.2337/db06-0574 · Cited by 110
“(7), both rs12255372 and rs7903146 in theTCF7L2 gene were associated with type 2 diabetes in European-derived Caucasian populations.”
BackgroundInfluentialRegulatory Mechanisms of the Wnt/β-Catenin Pathway in Diabetic Cutaneous Ulcers
Zhang, H., Nie, X., Shi, X., Zhao, J., Chen, Y., Yao, Q.-Y., Sun, C., & Yang, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01114 · Cited by 108
“It has been reported that in type 2 DM, nucleotide polymorphisms (SNPs) exist for TCF7L2 of the Wnt pathway (Grant et al., 2006).”
BackgroundYeh, C. Y., Aguirre, K., Laveroni, O., Kim, S., Wang, A., Liang, B., Zhang, X., Han, L. M., Valbuena, R., Bassik, M. C., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01943-5 · Cited by 103
Effects of the diabetes linked TCF7L2polymorphism in a representative older population
Melzer, D. R., Murray, A., Hurst, A. J., Weedon, M. N., Bandinelli, S., Corsi, A. M., Ferrucci, L., Paolisso, G., Guralnik, J. M., & Frayling, T. M. (2006) · BMC Medicine · doi:10.1186/1741-7015-4-34 · Cited by 96
“Our finding of higher rates of microvascular complications in T allele patients with diabetes is consistent with specific dysfunction of insulin production in the beta cell present with the TCF7L2 polymorphism[4], perhaps leading to greater exposure to hyperglycemia-mediated damage.”
BackgroundInfluentialNutrigenetics and Nutrigenomics Insights into Diabetes Etiopathogenesis
Berná, G., Oliveras‐López, M., Jurado‐Ruiz, E., Tejedo, J. R., Bedoya, F. J., Soria, B., & Martín, F. (2014) · Nutrients · doi:10.3390/nu6115338 · Cited by 107
Miyake, K., Horikawa, Y., Hara, K., Yasuda, K., Osawa, H., Furuta, H., Hirota, Y., Yamagata, K., Hinokio, Y., Oka, Y., et al. (2007) · Journal of Human Genetics · doi:10.1007/s10038-007-0231-5 · Cited by 91
Genomics of type 2 diabetes mellitus: implications for the clinician
Stolerman, E. S., & Florez, J. C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.129 · Cited by 102
“This study led to the discovery that the transcription factor 7-like 2 ( TCF7L2 ) gene on chromosome 10q has a comparatively strong effect on the risk of T2DM”
BackgroundRole of TCF7L2 risk variant and dietary fibre intake on incident type 2 diabetes
Hindy, G., Sonestedt, E., Ericson, U., Jing, X.-J., Zhou, Y., Hansson, O., Renström, E., Wirfält, E., & Orho-Melander, M. (2012) · Diabetologia · doi:10.1007/s00125-012-2634-x · Cited by 89
“Transcription factor 7-like 2 gene (TCF7L2) rs7903146 to this date remains the strongest and most widely replicated type 2 diabetes susceptibility locus [1, 2].”
BackgroundGeoghegan, G., Simcox, J., Seldin, M. M., Parnell, T. J., Stubben, C., Just, S. F., Begaye, L. J., Lusis, A. J., & Villanueva, C. J. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.03.003 · Cited by 104
“One of the strongest genetic predispositions for type 2 diabetes in humans is a variant of the Tcf7l2 gene [7].”
BackgroundVascular Injury During Elevated Glucose can be Mitigated by Erythropoietin and Wnt Signaling
Chong, Z. Z., Shang, Y. C., & Maiese, K. (2007) · Current Neurovascular Research · doi:10.2174/156720207781387150 · Cited by 90
TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden
Mayans, S., Lackovic, K., Lindgren, P., Ruikka, K., Ågren, Å., Eliasson, M., & Holmberg, D. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201773 · Cited by 98
Mechanisms underlying proglucagon gene expression
Jin, T. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0085 · Cited by 91
Takamoto, I., Kubota, N., Nakaya, K., Kumagai, K., Hashimoto, S., Kubota, T., Inoue, M., Kajiwara, E., Katsuyama, H., Obata, A., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3131-6 · Cited by 89
“Since 2006, numerous studies, including genome-wide association studies, have generally confirmed a strong association between singlenucleotide polymorphisms (SNPs) in the human gene encoding transcription factor 7-like 2 (TCF7L2) and the risk of onset of type 2 diabetes [3, 4].”
BackgroundGenetics of Type 2 Diabetes: Past, Present, and Future
Laakso, M., & Silva, L. F. (2022) · Nutrients · doi:10.3390/nu14153201 · Cited by 108
“identified the TCF7L2 locus in 2006 as a risk gene for T2D using the combination of linkage analysis and genotyping microsatellite markers across the chromosome 10q region in a study that included 1185 individuals with T2D and 931 controls [22].”
BackgroundSchäfer, S., Müssig, K., Staiger, H., Machicao, F. E., Stefan, N., Gallwitz, B., Häring, H.-U., & Fritsche, A. (2009) · Diabetologia · doi:10.1007/s00125-009-1344-5 · Cited by 92
“rs7903146 in intron 3 of the TCF7L2 gene was found to be the most significantly associated SNP with an increased risk of diabetes among persons with IGT [29, 34].”
BackgroundCraig, R. L., Chu, W. S., & Elbein, S. C. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.11.003 · Cited by 94
Metadata
- Authors
- Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., Styrkarsdottir, U., Magnusson, K. P., Walters, G. B., Palsdottir, E., Jonsdottir, T., Gudmundsdottir, T., Gylfason, A., Saemundsdottir, J., Wilensky, R. L., Reilly, M. P., Rader, D. J., Bagger, Y., Christiansen, C., Gudnason, V., Sigurdsson, G., Thorsteinsdottir, U., Gulcher, J. R., Kong, A., & Stefansson, K.
- Affiliations
- deCODE Genetics (Iceland) (IS)
- National University Hospital of Iceland (IS)
- University of Pennsylvania (US)
- Center for Clinical & Basic Research (DK)
- Icelandic Heart Association (IS)
- Corresponding author
- Grant, Struan F A
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-01-15
- Volume
- 38
- Issue
- 3
- Pages
- 320-323
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1965141016
- Cited by
- 2,287
- References
- 25
- Citations by year
- 2026: 45 · 2025: 58 · 2024: 54 · 2023: 56 · 2022: 80 · 2021: 86 · 2020: 76 · 2019: 86 · 2018: 86 · 2017: 85 · 2016: 99 · 2015: 109 · 2014: 125 · 2013: 125 · 2012: 156
- FWCI
- 127.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- University of Pennsylvania
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 2 diabetes, TCF7L2, transcription factor 7-like 2, chromosome 10q, genetic susceptibility, blood glucose homeostasis, Wnt signaling, Icelandic population, Danish population, United States population
- MeSH terms
- Chromosome Mapping, Chromosomes, Human, Pair 10, Denmark, Diabetes Mellitus, Type 2, Gene Frequency, Genetic Carrier Screening, Humans, Introns, Molecular Sequence Data, Reference Values, Cohort Studies, Microsatellite Repeats, Genetic Predisposition to Disease, TCF Transcription Factors, Transcription Factor 7-Like 2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.